# Indo Us Bio-Tech Ltd (INDOUS)
> Exchange: NSE | Sector: Chemicals | ISIN: 

## Price
Current Price: ₹100.95
Day Change: -0.71%
52W High: ₹205.1
52W Low: ₹95
Market Cap: ₹211 Cr

## Valuation
P/E: 14.19
P/B: 2.43
EPS: ₹7.4
Book Value: ₹43.18
Dividend Yield: 0%

## Returns
1Y Return: -21.93%

## Profitability
ROE: 0%
ROCE: 25.38%
Debt/Equity: 0.32
Revenue Growth: -3.2%
Profit Growth: -40.9%
EBITDA Margin: 15.77%
Operating Margin: 17.24%

## About
Indo Us Bio-Tech Ltd is a Agricultural Inputs company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Chemicals
Industry: Agricultural Inputs
Sub Industry: Unknown

## Business Model
Overview: Indo Us Bio-Tech Ltd makes money through Manufactured commodity sales, Value-added products, Exports or institutional demand in Agricultural Inputs. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Chemicals.
Source: Derived from stock data
Revenue Streams:
- Manufactured commodity sales
- Value-added products
- Exports or institutional demand
Operating Model:
- Uses plants, mines, or processing assets to convert raw materials into industrial products.
- Realisation, utilisation, energy cost, logistics, and commodity cycles drive earnings.
Recent Context:
- Announcement: Non-Applicability Of Large Corporate Criteria As Per SEBI Circular Dated November 26, 2018
- Announcement: Announcement under Regulation 30 (LODR)-Resignation of Director
- BSE Filing: Non-Applicability Of Large Corporate Criteria As Per SEBI Circular Dated November 26, 2018

## Access
Current tier: anonymous
More history: Register free to see 3 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:11.526Z
Price History Updated: 2026-05-18T22:59:37.475Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:37.475Z
Quant Updated: 2026-05-18T22:59:37.475Z
Sentiment Updated: 2026-05-18T22:59:37.475Z
Financials Status: current
Financials Updated: 2026-05-18T23:03:06.966Z
Financials Last Attempt: 2026-05-18T23:03:06.966Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹103.84 Cr
Operating Profit: ₹18.01 Cr (OPM 17.34%)
Net Profit: ₹16.27 Cr
Tax: ₹0.26 Cr

## Annual P&L History
FY25: Rev ₹103.84Cr | PAT ₹16.27Cr | OPM 17.34%
FY24: Rev ₹72.84Cr | PAT ₹8.24Cr | OPM 14.22%
FY23: Rev ₹61.74Cr | PAT ₹7.24Cr | OPM 13.91%

## Balance Sheet (FY25)
Total Assets: ₹97.84 Cr
Total Liabilities: ₹19.32 Cr
Borrowings: ₹14.84 Cr
Cash: ₹0.25 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Jagdishkumar Devjibhai Ajudia, Chairman & MD
- Rinku Dipenbhai Jethva, Chief Finance Officer
- Dimpy Divyangbhai Joshi, Company Secretary & Compliance Officer
- Priyanka Jagdishbhai Ajudia, Executive & Non-Independent Director
- Maltiben Jagdishkumar Ajudia, Whole Time Director

---
Source: rupiya.io/stocks/indous
Disclaimer: For research and education only. Not investment advice.